A recent ruling by Texas-based U.S. District Judge Matthew J. Kacsmaryk that could stay the Food and Drug Administration's approval of mifepristone, a medication used in more than 50% of abortions, has been met with outrage from Democrats. They have vowed to use every tool available to protect access to mifepristone, which could be limited not only in Texas but also across the country if this ruling goes into effect. The Biden administration has already filed its notice of appeal in the Fifth Circuit to fight Judge Kacsmaryk's ruling. Meanwhile, Republicans have remained largely silent, reflecting the divide in the politics around abortion. Strategists believe that anger over abortion bans helped sink Republicans in critical races in the midterms, and Democrats are making the issue central to their attacks on declared and potential candidates for the GOP presidential nomination in 2024. The Texas decision does not go into effect for seven days, and a judge in Washington state has ordered the FDA to preserve the "status quo."